StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GENO.OL$23.45-0.21%
Fair $23.45+0.0%

GENO.OL

GENO.OL

Technology / Scientific & Technical InstrumentsOslo

$23.45

-0.05 (-0.21%)

Fairly Valued+0.0%Fair Value $23.45Fund rank 35/100 · Data gapFallback financials|
SA 42/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $112.3M · quality 70.3/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 64/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

12/100

SEC 0%

Latest source: unknownPeriods: 3Warnings: 0unknown: 3
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · GENO.OLLocal privado en este navegador · GENO.OL
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.4B

P/E

30.1x

↑

EV/EBITDA

16.6x

↑

ROE

23.3%

↑

Gross Margin

64.1%

↑

Debt/Equity

0.22

↑
52-Week Range$23
$22$33

TradingView lightweight chart

GENO.OL price, volumen y niveles de valoración

Último $23.45Periodo -1.1%
Fair value: $23.45

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2025 · 2 años de histórico normalizado

Revenue CAGR

+25.8%

FCF CAGR

+220.2%

FCF margin

13.4%

FCF / Net income

1.04x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.28B · net income $165.1M · FCF $171.8M

2023-FY → 2025-FY

Gross margin

64.1%-5.2% pts

Operating margin

14.2%+5.4% pts

Net margin

12.9%+21.9% pts

FCF margin

13.4%+11.3% pts
MetricTTM
2025
2024
2023
Income Statement
Revenue$1.28B$1.28B$957.1M$808.8M
Net Income$165.1M$165.1M$39.2M$-72.5M
EBITDA$260.6M$260.6M$167.8M$30.5M
EPS0.860.860.20-0.38
Gross Margin64.1%64.1%66.6%69.3%
Operating Margin14.2%14.2%6.7%8.8%
Net Margin12.9%12.9%4.1%-9.0%
Balance Sheet
Debt/Equity0.220.220.380.35
Current Ratio1.661.66——
Cash Flow
Free Cash Flow$171.8M$171.8M$112.3M$16.8M
Returns
ROE23.3%23.3%5.5%-11.6%
Valuation
P/E30.0630.06——
EV/EBITDA16.6016.60——
P/B6.376.37——
Growth & Yield
Revenue Growth33.8%33.8%18.3%—
EPS Growth321.3%321.3%154.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

34.3%

muy exigente

EPS terminal req.

$2.08

Spread vs growth

287.0%

5Y implied EPS CAGR

24.0%

exigente

EPS terminal req.

$2.52

Spread vs growth

297.3%

10Y implied EPS CAGR

16.8%

exigente

EPS terminal req.

$4.05

Spread vs growth

304.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total -1.1%

Total return

-1.1%

Start / end P/E

116.3x → 27.3x

EPS bridge

0.20 → 0.86

Residual

-245.9%

EPS growth+321.3%
Multiple rerating-76.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term-245.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.